Low-Tech Treatments for Obstructive Sleep Apnea
Myofunctional Therapy for Obstructive Sleep Apnea in U.S. Service Members With and Without Traumatic Brain Injury
2 other identifiers
interventional
60
1 country
1
Brief Summary
The overall purpose of this study is to compare changes in sleep outcomes in people with obstructive sleep apnea (OSA) depending on their participation in one of two behavioral interventions; both involve drinking water and breathing. A second purpose is to compare outcomes between people who have sustained a traumatic brain injury (TBI) and those with no history of TBI. The main questions it aims to answer are whether sleep quality improves after 3-months of high-resistance versus low-resistance exercises, and whether people have different outcomes depending on their history of TBI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedStudy Start
First participant enrolled
January 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
February 17, 2026
December 1, 2025
1.6 years
November 5, 2025
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Apnea-Hypopnea Index (AHI)
AHI is the number of apneic and hypopneic episodes per hour of sleep. The scores start at zero, meaning no events are taking place. A mild score falls in the range of 5-15; moderate 15-30, and a severe diagnosis is 30 or more events per hour. Pre-intervention AHI is obtained from standard-of-care in-clinic sleep study. Post-intervention AHI is obtained from an in-clinic sleep study conducted as part of this research.
From enrollment to end of three-month intervention
Secondary Outcomes (4)
SpO2
From enrollment to end of three-month intervention
Snore Index
From enrollment to end of three-month intervention
Epworth Sleepiness Scale (ESS)
From enrollment to end of three-month intervention with option for additional three-week follow-up
Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10)
From enrollment to end of three-month intervention with option for additional three-week follow-up
Other Outcomes (4)
Tongue Strength
From enrollment to end of three-month intervention with option for additional three-week follow-up
Tongue Endurance
From enrollment to end of three-month intervention with option for additional three-week follow-up
Maximal Inspiratory Pressure (MIP)
From enrollment to end of three-month intervention with option for additional three-week follow-up
- +1 more other outcomes
Study Arms (2)
Myofunctional Therapy
EXPERIMENTALRelaxation Therapy
SHAM COMPARATORInterventions
Three months of drinking at least 32-oz of water daily through a high-resistance nozzle, and inhaling and exhaling 60 times per day through a high-resistance breathing device
Three months of drinking 32-oz of water daily through a low-resistance nozzle, and inhaling and exhaling 40 times per day through a low-resistance breathing device
Eligibility Criteria
You may qualify if:
- New diagnosis of OSA (AHI, ≥ 5) or failure of first-line OSA treatment;
- Willingness to forego first-line OSA treatment or stop current OSA treatment for 3 months;
- Ability to follow directions and perform the required exercises;
- Age between 18-65 yr.
You may not qualify if:
- Current use of OSA treatment;
- Medical comorbidities that require restricting fluid intake (e.g., dysphagia, renal disease, liver disease, hyponatremia);
- Severe nasal obstruction; 4) severe ankyloglossia; 4) craniofacial abnormality; 5) severe pulmonary disease; 6) severe post-traumatic stress disorder; 7) very severe insomnia; 8) body mass index (BMI) ≥30 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Walter Reed National Military Medical Center
Bethesda, Maryland, 20889, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2025
First Posted
December 24, 2025
Study Start
January 29, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
February 17, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The study protocol was developed during grant-proposal preparation. Investigators communicate regularly to share updates and coordinate procedures for study implementation. IPD will be made available periodically throughtout data-collection and during data analysis and dissemination (anticipated Jan 2026 -- Dec 2028).
- Access Criteria
- The WRNMMC/USUHS research team will share coded data with project-related Geneva Foundation contractors and UMN collaborators. The coded data will be stored on REDCap, housed on an encrypted password- and firewall-protected server. Authorized project personnel may request IPD through the PIs.
Per a Data Sharing Agreement, de-identified primary and secondary outcome data from Walter Reed National Military Medical Center will be shared with investigators at Uniformed Services University of the Health Sciences, contractors with the Geneva Foundation, and colleagues at University of Minnesota (UMN). UMN colleagues are conducting a concurrent study using the same procedures as the experimental arm; both sites plan to pool data for a larger sample size.